Document is current
Any future updates will be listed below
-
Authors
Constantinescu, Andrei-Emil
Bull, Caroline J.
Goudswaard, Lucy J.
Zheng, Jie
Elsworth, Benjamin
Timpson, Nicholas J.
Moore, Samantha F.
Hers, Ingeborg
Vincent, Emma E.
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/N0137941/1, MC_UU_00011/1, MC_UU_00011/1, MC_UU_00011/1, MC_UU_00011/1)
Cancer Research UK (C18281/A29019, C18281/A29019, C18281/A29019)
Diabetes UK (17/0005587, 17/0005587)
World Cancer Research Fund International (IIG_2019_2009, IIG_2019_2009)
Health Data Research UK
British Heart Foundation (AA/18/1/34219, PG/16/3/31833, PG/16/3/31833)
Shanghai Thousand Talents Program and the National Health Commission of the PR China (SBF006\1117)
Our Future Health
Wellcome Trust (217065/Z/19/Z, 204813/Z/16/Z)
NIHR Bristol Biomedical Research Centre (BRC-1215-2001)
EPSRC Prostanoid Programme, United Kingdom (EP/M012530/1, EP/M012530/1)
- License Information
-
More Information
Article History
Received: 31 May 2023
Accepted: 20 October 2023
First Online: 11 November 2023
Declarations
:
: UK Biobank received ethical approval from the NHS National Research Ethics Service North West (11/NW/0382; 16/NW/0274) and was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent before enrolment in the study. Ethical approval for ALSPAC was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Consent for biological samples has been collected in accordance with the Human Tissue Act (2004). Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time.
: Consent for publication-not applicable.
: The authors declare no competing interests.
